Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2007, for WellPoint, Inc. (now Elevance Health). WellPoint is the largest health benefits company in the United States by commercial membership, serving approximately 34.8 million members as of the reporting date. The company operates through three reportable segments: Commercial and Consumer Business (CCB), Specialty, Senior and State-Sponsored Business (4SB), and Other (including Federal Government Solutions). The company is an independent licensee of the Blue Cross and Blue Shield Association.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2007 | Six Months Ended June 30, 2006 |
|---|---|---|
| Total Revenues | $30,339.0 million | $28,009.6 million |
| Net Income | $1,618.3 million | $1,483.0 million |
| Diluted EPS | $2.61 | $2.26 |
| Operating Cash Flow | $2,707.0 million | $1,998.6 million |
| Benefit Expense Ratio | 82.5% | 81.2% |
| SG&A Expense Ratio | 14.7% | 15.8% |
| Total Assets | $54,194.1 million | $51,574.9 million |
| Total Liabilities | $29,205.3 million | $26,999.1 million |
| Long-Term Debt | $7,652.2 million | $6,493.2 million |
| Cash and Cash Equivalents | $4,205.1 million | $2,602.1 million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 8% year-over-year, driven by premium rate increases in Local Group, growth in State-Sponsored business (addition of five new states), and increased reimbursement in the Federal Employee Program (FEP).
- Profitability: Net income rose 9% to $1.6 billion. Diluted EPS increased 15% to $2.61, aided by a reduction in the weighted average shares outstanding due to stock repurchases.
- Expense Trends: Benefit expense increased 10% to $22.8 billion. The benefit expense ratio increased 130 basis points to 82.5%, primarily due to higher claims experience in State-Sponsored business and Medicare Part D seasonality. Conversely, the SG&A expense ratio improved by 110 basis points to 14.7% due to operational leverage.
- Investment Activity: Net investment income increased 16% to $500.0 million due to higher interest rates and reinvestment of operating cash. The company recorded $107.8 million in other-than-temporary impairment charges for the six-month period.
- Debt Issuance: In June 2007, the company issued $1.5 billion in long-term notes ($700 million due 2017 and $800 million due 2037) to fund working capital and share repurchases.
Guidance, Outlook, and Risks
- Cost of Care Outlook: Management maintains a 2007 medical cost trend estimate of less than 8%. They expect the benefit expense ratio for State-Sponsored business to moderate later in 2007 following premium rate negotiations and provider re-contracting.
- Tax Rate: The effective tax rate for the first six months was 36.9%. Management expects the full-year 2007 effective tax rate to be 36.8%.
- Strategic Acquisitions: On July 9, 2007, WellPoint announced an agreement to acquire American Imaging Management (AIM) for approximately $300 million in cash to enhance radiology benefit management.
- Capital Allocation: The company continues an aggressive stock repurchase program. As of June 30, 2007, $1.0 billion remained authorized. Subsequent to the period end, an additional $310 million was spent, leaving approximately $682 million authorized.
- Risks and Contingencies:
- Litigation: The company is involved in the "Love Litigation" (RICO claims), which was settled in April 2007 with no expected material financial impact. Arbitration with John Hancock regarding reinsurance arrangements is pending.
- Regulatory: Ongoing investigations by California state agencies regarding policy rescissions and fair-claims handling. The company believes potential liabilities are unlikely to be material.
- Reserving: Significant judgment is required for medical claims payable ($5.7 billion). Variability in completion and trend factors could impact future earnings.
Investor Verification Checklist
- State-Sponsored Claims Experience: Verify the impact of the five new states on the benefit expense ratio and the success of ongoing premium rate negotiations.
- Medical Claims Reserves: Review the actuarial assumptions for completion and trend factors, noting the $356.1 million in prior year redundancies recognized in the first half of 2007.
- Investment Portfolio: Assess the $107.8 million in other-than-temporary impairment charges and the exposure to interest rate risk in the $18.1 billion investment portfolio.
- Regulatory Exposure: Monitor the outcome of California Department of Managed Health Care and Department of Insurance investigations regarding policy rescissions.
- Debt Servicing: Confirm the impact of the new $1.5 billion debt issuance on future interest expense and liquidity.